Faculty

Institution

Unit

Venue

Brian Brinkerhoff, M.D.

Associate Professor of Pathology & Laboratory Medicine Vice Chair of Anatomic Pathology Director Surgical Pathology Program Director Gastrointestinal Pancreaticobiliary and Liver Pathology Fellowship

Oregon Health & Science University

Affiliations

School of Dentistry

Department of Pathology and Radiology

Brian Brinkerhoff, M.d. is currently serving as a Pathology And Radiology Associate Professor of Pathology & Laboratory Medicine Vice Chair of Anatomic Pathology Director Surgical Pathology Program Director Gastrointestinal Pancreaticobiliary and Liver Pathology Fellowship at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Brian Brinkerhoff, M.D.

Oregon Health & Science University

Associate Professor of Pathology & Laboratory Medicine Vice Chair of Anatomic Pathology Director Surgical Pathology Program Director Gastrointestinal Pancreaticobiliary and Liver Pathology Fellowship

You can click a keyword to filter the displayed items

pathology oncology gastrointestinal oncology pancreatic cancer cancer research molecular cancer urology immunology cancer cells surgical oncology cancer discovery oncogenes cancer treatment colorectal cancer medicine hematology gastroenterology metastasis jama oncology molecular diagnostics carcinogenesis inflammatory bowel disease gastrointestinal surgery digestive diseases cancer care cancer biology immune checkpoint inhibitors hereditary hemorrhagic telangiectasia pancreatic ductal adenocarcinoma biomarker discovery platform medical imaging cellular therapy clinical otolaryngology cancer imaging biomedical imaging surgical pathology cell research novel therapies tolerance induction otorhinolaryngology upper gastrointestinal surgery cancer detection functional gastrointestinal disorders clinical gastroenterology cancer management colorectal surgery genitourinary cancers tumor heterogeneity cancer genomics prostatic disease cellular immune responses pancreatic surgery ulcerative colitis quality improvement surgical quality control surgical training biomarker target biomarker discovery prognostic biomarkers cancer growth radiation therapy content representation narrative summarization long-term therapy uncommon locations appendiceal gists risk assessment gastrointestinal stromal tumors lung recurrence replication stress tolerance renal pathology resectable intrahepatic cholangiocarcinoma tumor multifocality oncologic outcomes adjuvant chemotherapy resected ampullary cancer translational research liver physiology molecular gastroenterology clinical research pancreatitis hepatology histopathology cancer letter gross anatomy surgery oral diseases gastrointestinal endoscopy diagnosis oral medicine health sciences oral pathology internal medicine anatomical pathology digestive endoscopy oral biology translational medicine radiology oral radiology scleroderma

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cell Fusion Reprograms Tumor Cells and Promotes Runx1-Mediated Invasion and Dissemination in Colorectal Cancer. bioRxiv (Cold Spring Harbor Laboratory) (2026)

oncogenesmetastasispathologycolorectal cancertumor biologycell biologycarcinogenesisrunx1-mediated invasioncancer growthcancer cellscell fusion reprogramscancer biology

Phase Ib Study to Assess the Safety of Neoadjuvant Trifluridine/Tipiracil With Concurrent Radiation in Resectable Stage II/III Rectal Cancer: The Fierce Study. Clinical Colorectal Cancer (2026)

radiation therapyradiation oncologycancer caresurgical oncologyconcurrent radiationmedicinefierce studyradiationphase ib studycancer treatmentclinical trialsoncology

1756 Engaging Pathology Residents in Surgical Pathology Quality Assurance Practices. Laboratory Investigation (2025)

quality improvementsurgical quality controlsurgerymedical educationsurgical educationnursinginternal medicinequality managementengaging pathology residentssurgical training

Ongoing Replication Stress Tolerance and Clonal T Cell Responses Distinguish Liver and Lung Recurrence and Outcomes in Pancreatic Cancer. Nature Cancer (2025)

tolerance inductionimmunologycell biologycellular therapycarcinogenesiscancer researchpancreatic cancerlung recurrencecancer cellsreplication stress toleranceoncology

Abstract B003: Advancing Biomarker Discovery Using a Novel Window of Opportunity (Woo) Trial for Pancreatic Ductal Adenocarcinoma: Trial Updates. Cancer Research (2024)

biostatisticsoncogenespathologygastrointestinal oncologyprognostic biomarkersbiomarker discoverytrial updatesbiomarker targetmolecular cancercancer researchmolecular diagnosticscancer discoverypancreatic cancerbiomarkersoncologynovel window

CASPER: A Phase I Trial Combining Calaspargase Pegol-Mnkl and Cobimetinib in Pancreatic Cancer. Future Oncology (2024)

radiation oncologycancer immunotherapymolecular cancercancer discoveryjama oncologypharmacologypancreatic cancercancer treatmentoncology

Combinatorial Inhibition of Complement Factor D and Bcl2 for Early-Onset Colorectal Cancer. Diseases of the Colon & Rectum (2024)

complement factor doncogenescolorectal cancerpathologygastrointestinal oncologytumor biologyimmunologycell biologymolecular cancercombinatorial inhibitionmolecular gastroenterologytherapeutic targetsearly-onset colorectal cancercancer cellsimmune checkpoint inhibitorsoncologycancer biology

Mixed Adenosquamous Cell Carcinoma of the Prostate With Paired Sequencing on the Primary and Liver Metastasis. Current Oncology (2024)

metastasispathologyliver metastasissurgical pathologyprostate cancergenitourinary cancersprostatic diseasemolecular diagnosticsurologytumor heterogeneitycancer genomicsoncology

Neoadjuvant Immunotherapy Leads to Complete Pathologic Response in Locally Advanced Colon Cancer. Clinical Case Reports (2024)

colorectal cancerpathologygastrointestinal oncologycancer immunotherapyimmunologyimmunotherapyjama oncologymolecular gastroenterologyadvanced colon cancerpathologic responseimmune checkpoint inhibitorsoncologyneoadjuvant immunotherapy

A Window of Opportunity Trial for Metastatic (Woo-M) Pancreatic Ductal Adenocarcinoma (Pdac): A Biomarker Discovery Platform.. Journal of Clinical Oncology (2023)

metastasispathologyradiation oncologygastrointestinal oncologymolecular canceropportunity trialbiomarker discovery platformpancreatic ductal adenocarcinomacancer researchmolecular diagnosticscancer discoverypancreatic cancerbiomarkerscancer cellsoncology

1
2
3
10 / page

Brian Brinkerhoff, M.D.

Associate Professor of Pathology & Laboratory Medicine Vice Chair of Anatomic Pathology Director Surgical Pathology Program Director Gastrointestinal Pancreaticobiliary and Liver Pathology Fellowship

Oregon Health & Science University

Affiliations

School of Dentistry

Department of Pathology and Radiology

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Brian Brinkerhoff, M.D.

Oregon Health & Science University

Associate Professor of Pathology & Laboratory Medicine Vice Chair of Anatomic Pathology Director Surgical Pathology Program Director Gastrointestinal Pancreaticobiliary and Liver Pathology Fellowship

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cell Fusion Reprograms Tumor Cells and Promotes Runx1-Mediated Invasion and Dissemination in Colorectal Cancer. bioRxiv (Cold Spring Harbor Laboratory) (2026)

oncogenesmetastasispathologycolorectal cancertumor biologycell biologycarcinogenesisrunx1-mediated invasioncancer growthcancer cellscell fusion reprogramscancer biology

Phase Ib Study to Assess the Safety of Neoadjuvant Trifluridine/Tipiracil With Concurrent Radiation in Resectable Stage II/III Rectal Cancer: The Fierce Study. Clinical Colorectal Cancer (2026)

radiation therapyradiation oncologycancer caresurgical oncologyconcurrent radiationmedicinefierce studyradiationphase ib studycancer treatmentclinical trialsoncology

1756 Engaging Pathology Residents in Surgical Pathology Quality Assurance Practices. Laboratory Investigation (2025)

quality improvementsurgical quality controlsurgerymedical educationsurgical educationnursinginternal medicinequality managementengaging pathology residentssurgical training

Ongoing Replication Stress Tolerance and Clonal T Cell Responses Distinguish Liver and Lung Recurrence and Outcomes in Pancreatic Cancer. Nature Cancer (2025)

tolerance inductionimmunologycell biologycellular therapycarcinogenesiscancer researchpancreatic cancerlung recurrencecancer cellsreplication stress toleranceoncology

Abstract B003: Advancing Biomarker Discovery Using a Novel Window of Opportunity (Woo) Trial for Pancreatic Ductal Adenocarcinoma: Trial Updates. Cancer Research (2024)

CASPER: A Phase I Trial Combining Calaspargase Pegol-Mnkl and Cobimetinib in Pancreatic Cancer. Future Oncology (2024)

radiation oncologycancer immunotherapymolecular cancercancer discoveryjama oncologypharmacologypancreatic cancercancer treatmentoncology

Combinatorial Inhibition of Complement Factor D and Bcl2 for Early-Onset Colorectal Cancer. Diseases of the Colon & Rectum (2024)

Mixed Adenosquamous Cell Carcinoma of the Prostate With Paired Sequencing on the Primary and Liver Metastasis. Current Oncology (2024)

metastasispathologyliver metastasissurgical pathologyprostate cancergenitourinary cancersprostatic diseasemolecular diagnosticsurologytumor heterogeneitycancer genomicsoncology

Neoadjuvant Immunotherapy Leads to Complete Pathologic Response in Locally Advanced Colon Cancer. Clinical Case Reports (2024)

A Window of Opportunity Trial for Metastatic (Woo-M) Pancreatic Ductal Adenocarcinoma (Pdac): A Biomarker Discovery Platform.. Journal of Clinical Oncology (2023)

1
2
3
10 / page